Category: Legal & Regulatory Issues

Danco settles for $765K in mifepristone case

Danco Laboratories agreed to pay $765,000 April 12 to settle accusations of the drug distributor importing active pharmaceutical ingredients for its one drug, Mifeprex (mifepristone), and not marking its country of origin or paying marking duties. 

Florida restricts abortion access to 6 weeks

Hours after the Florida Legislature sent a bill that places a six-week ban on abortions to Gov. Ron DeSantis’ desk, he signed it into law, according to an April 13 statement from his office.

Former physician acquitted of patient deaths sues Trinity 

A former physician acquitted in the death of 14 patients is suing Livonia, Mich.-based Trinity Health for malicious prosecution, according to court documents obtained by Becker’s.

Former Kentucky nurse pleads guilty to 2nd degree manslaughter in patient death

A former Kentucky nurse has pleaded guilty to manslaughter of a patient after initially being charged with murder, Lexington Herald Leader reported April 13.

Florida lawmakers move to restrict abortion access to 6 weeks

Florida stands to be one of the most restrictive states in the country when it comes to abortion, if Gov. Ron DeSantis signs legislation passed April 13 that would prohibit abortions after six weeks, according to The New York Times.

Union alleges California hospital laid off workers to avoid minimum wage law

Service Employees International Union-United Healthcare Workers West is suing a California hospital, alleging the facility laid off employees instead of complying with a new city minimum pay law, according to mynewsla.com.

Kaiser Permanente hospital struck by gunfire

An unknown person opened fire on Kaiser Permanente’s Roseville (Calif.) hospital, striking the building, CBS Sacramento reported April 12.

Washington, DC-area physician charged with illegal opioid distribution

Ndubuisi Joseph Okafor, MD, a physician based in Washington, D.C., has been arrested and charged with 16 counts of illegal distribution of opioids.

FTC puts health companies on watch for misleading ads

Nearly 700 companies are receiving a warning from the Federal Trade Commission about the civil penalties they face for advertisements containing claims about products that cannot be backed up with reliable evidence. 

10 medical associations react to Texas abortion pill ruling

In the days since the Texas federal court ruling that suspended the FDA’s approval of mifepristone — one of two pills used to induce abortion medically — several medical associations reacted to the unprecedented case.